abstract |
The invention provides modulators for the orphan nuclear receptor ROR ϒ and methods for treating ROR ϒ mediated diseases by administrating these novel ROR ϒ modulators to a human or a mammal in need thereof. Specifically, the present invention provides pyrrolo carboxamide compounds of Formula (1) and the enantiomers, diastereomers, N -oxides, tautomers, solvates and pharmaceutically acceptable salts thereof. |